Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by stockpatrolon Nov 18, 2022 6:25pm

AGN.c officially screening subjects for DMT Phase 1 clinical

AGN.c officially screening subjects for DMT Phase 1 clinical trials for treatment of stroke.    https://twitter.com/StckMasterFlash/status/1592966259284799488   There will be a ...more  
125
Post by biggonadson Nov 17, 2022 2:54pm

AGN progress on DMT clinical stroke research program

Algernon Pharmaceuticals announces that they’ve initiated their DMT clinical stroke research program with their Phase 1 study in the Netherlands. The release today indicates the progress of this ...more  
153
Post by waves1on Nov 16, 2022 2:25pm

AGN commences screening for DMT study subjects

AGN has commenced screening for the subjects in its Phase I DMT human stoke study! Conducted in the Netherlands, AGN expects to open enrolment shortly and dose the first subject of the study in ...more  
141
Discussion
Post by stockpatrolon Nov 15, 2022 6:11pm

AGN.c has been making steady progress advancing to phase 1

AGN.c has been making steady progress advancing to phase 1 clinical trial for DMT treatment of stroke.    https://twitter.com/StocksNThoughts/status/1592264234435772418   Last ...more  
128
Discussion
Post by SkywalkerofLukeon Nov 14, 2022 4:09pm

Recent News

AGN.c AGNPF has had a steady stream of news over the past several weeks. Last month they entered an Investigator-Initiated Clinical Trial Agreement with Yale University for the investigation of DMT ...more  
109
Post by stockpatrolon Nov 11, 2022 6:15pm

AGN.c has been approved for phase 1 clinical trials.

AGN.c has been approved for phase 1 clinical trials.    https://twitter.com/big_gonads/status/1590781335890587648   Very little trials are currently taking place for DMT ...more  
121
Post by biggonadson Nov 10, 2022 2:41pm

AGN approved for phase 1 clinical trials for DMT

Algernon reaches another milestone with the approval to commence phase 1 clinical trials in its investigation of DMT in treating ischemic stroke. This treatment will tap into a market worth $15B ...more  
100
Post by stockpatrolon Nov 09, 2022 6:59pm

AGN.c closing up 13% today.

AGN.c closing up 13% today.    https://twitter.com/Chris65212739/status/1590380550761910272   They were featured on CEO Clips recently discussing their Phase 1 study of DMT for ...more  
133
Post by waves1on Nov 08, 2022 1:58pm

"Advancing DMT into a Phase 1 Clinical Trial" + up 12%!

AGN killing it today w/ a 12% jump! Check out AGN's CEO ...more  
109
Post by waves1on Nov 07, 2022 4:48pm

AGN trading green + presentations from Wonderland Miami

Check out AGN's presentations from Wonderland Miami from last week: Business Presentation: https://algernonpharmaceuticals.com/wp-content/uploads/2018/01/Wonderland-Algernon-Christopher-Moreau ...more  
143
Post by StockHawk1on Nov 04, 2022 6:08pm

AGN presenting tomorrow at Wonderland

Algernon Pharmaceuticals (AGN.c AGNPF) is presenting a keynote address at the Wonderland Psychedelic Medicine event tomorrow at 2pm EST.  AGN's CEO will be presenting alongside Dr. Rick ...more  
176
Post by StockHawk1on Nov 03, 2022 5:19pm

AGN files for Orphan Designation for Ifenprodil on IPF

Algernon Pharmaceuticals (AGN.c AGNPF) recently advanced its investigation of Ifenprodil for the treatment of the chronic lung condition IPF by filing a request to the FDA for Orphan Designation for ...more  
136
Post by StockHawk1on Nov 01, 2022 2:30pm

AGN.c--Yale partnership

Algernon Pharmaceuticals (AGN.c AGNPF) recently entered into a Clinical Trial Agreement with Yale University for their study on using DMT to treat depression. AGN is providing DMT for the study and ...more  
222
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next